MONTREAL and CHARLOTTE, N.C., Feb. 25, 2021 /PRNewswire/ -- Milestone
Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical
company focused on the development and commercialization of
innovative cardiovascular medicines, today announced
that Joseph Oliveto, President and Chief Executive Officer,
will present at the following investor conferences:
- The Cowen 41st Annual Health Care Conference's panel
on Cardiovascular Disease and Hospital Products on Thursday, March 4, 2021 at 1:30 p.m. Eastern Time.
- The H.C. Wainwright Global Life Sciences Conference on
Tuesday, March 9, 2021 on demand
beginning at 7:00 a.m. Eastern
Time.
- The Oppenheimer 31st Annual Healthcare Conference on
Tuesday, March 16, 2021 at
10:00 a.m. Eastern Time.
A replay of the pre-recorded H.C. Wainwright presentation and
live webcast Oppenheimer presentation can be accessed in the News
& Events section of Milestone's website
at www.milestonepharma.com. An archived replay of the webcasts
will be available on the same website for approximately 90 days
following the presentations.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals is a biopharmaceutical company focused
on the development and commercialization of etripamil, a Phase 3
clinical-stage program, for the treatment of cardiovascular
indications. Milestone Pharmaceuticals operates in Canada and the
United States. For more information, visit
www.milestonepharma.com and follow the Company on Twitter at
@MilestonePharma.
Contact
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301235125.html
SOURCE Milestone Pharmaceuticals, Inc.